Table 1.
Demographic data.
| LmLf (n = 18) | HmLf (n = 13) | LmSf (n = 20) | HmSf (n = 15) | P | |
|---|---|---|---|---|---|
| Gender (Male) | 16 | 12 | 18 | 13 | 0.830 |
| Age | 55.17 ± 7.06 | 53.62 ± 9.16 | 52.20 ± 11.65 | 50.07 ± 15.55 | 0.221 |
| Hepatic carcinoma | 9 | 4 | 8 | 3 | 0.309 |
| MELD score | 3.94 ± 2.45a | 28.85 ± 4.67b | 4.45 ± 2.61c | 29.8 ± 5.94d | 0.000 |
| Follow-up period | 56.78 ± 15.16a | 56.38 ± 16.52c | 16.95 ± 5.60b | 18.07 ± 5.90d | 0.000 |
Lm, low MELD score; Hm, high MELD score; Sf, short-term follow-up; Lf, long-term follow-up; MELD, a model for end-stage liver disease.
a vs. b, a vs. d, c vs. b, and c vs. d, p < 0.001.